/
RSS Feed
ORLANDO—Primary mediastinal large B cell lymphoma responded excellently to a dose-dense schedule of R-CHOP immuno-chemotherapy followed by ICE chemotherapy — without the need for radiotherapy — in a study from New York reported at the American Society of Hematology annual meeting in Orlando. eCancer Radio’s Hematology Editor, George Canellos, of the Dana-Farber Cancer Institute in Boston discusses the importance of these findings.
ASH TELEVISION NEWS REPORTS:
For full coverage of the American Society of Hematology’s 2010 Orlando meeting, visit www.eCancerMedicalScience.com for eCancerTV
LISTEN
[audio:https://www.audiomedica.com/podcasting/ecancer/101209GeorgeCanellos420PODCASTLoRes.mp3]
